Oak Harbor Wealth Partners’s AbbVie ABBV Stock Holding History

Oak Harbor Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$890K	Buy	4,094 +37	+0.9%	+$8.21K	0.21%	102
2025 Q4	$927K	Sell	4,057 -26	-0.6%	-$5.92K	0.22%	102
2025 Q3	$945K	Hold	4,083	–	–	0.23%	95
2025 Q2	$758K	Hold	4,083	–	–	0.2%	103
2025 Q1	$855K	Buy	4,083 +13	+0.3%	+$2.53K	0.24%	88
2024 Q4	$723K	Hold	4,070	–	–	0.21%	99
2024 Q3	$804K	Buy	4,070 +157	+4%	+$29.3K	0.23%	98
2024 Q2	$671K	Sell	3,913 -175	-4%	-$29K	0.21%	98
2024 Q1	$744K	Sell	4,088 -100	-2%	-$17.2K	0.23%	92
2023 Q4	$649K	Sell	4,188 -100	-2%	-$14.6K	0.22%	99
2023 Q3	$639K	Sell	4,288 -131	-3%	-$19.2K	0.23%	97
2023 Q2	$595K	Buy	4,419 +100	+2%	+$14.7K	0.2%	102
2023 Q1	$688K	Sell	4,319 -58	-1%	-$8.87K	0.25%	84
2022 Q4	$707K	Hold	4,377	–	–	0.27%	79
2022 Q3	$587K	Hold	4,377	–	–	0.23%	88
2022 Q2	$670K	Sell	4,377 -230	-5%	-$35.1K	0.27%	82
2022 Q1	$747K	Buy	4,607 +30	+0.7%	+$4.36K	0.25%	83
2021 Q4	$620K	Buy	+4,577	New	+$541K	0.21%	89

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oak Harbor Wealth Partners's ABBV Position: Q1 2026 in Review

Oak Harbor Wealth Partners increased its AbbVie (ABBV) stake by 0.91% in Q1 2026, buying an estimated $8.21K and bringing the position to 4,094 shares worth $890K. The position accounts for 0.21% of the portfolio, ranked #102.

Oak Harbor Wealth Partners first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $945K in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Oak Harbor Wealth Partners held 4,094 shares of AbbVie worth $890K as of Q1 2026.
Oak Harbor Wealth Partners bought 37 AbbVie shares in Q1 2026, an estimated $8.21K.
AbbVie made up 0.21% of Oak Harbor Wealth Partners's portfolio in Q1 2026, its #102 holding.
Oak Harbor Wealth Partners first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
Oak Harbor Wealth Partners's AbbVie position peaked at $945K in Q3 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Oak Harbor Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.